Salgia R[au] - Search Results

Year	Number of Results
1986	1
1987	2
1989	1
1992	1
1993	2
1994	3
1995	5
1996	4
1997	12
1998	4
1999	6
2000	8
2001	5
2002	12
2003	20
2004	13
2005	8
2006	7
2007	18
2008	21
2009	18
2010	17
2011	32
2012	25
2013	25
2014	35
2015	25
2016	26
2017	24
2018	31
2019	32
2020	49
2021	51
2022	14

1

Retraction.

Brand TM, Iida M, Corrigan KL, Braverman CM, Coan JP, Flanigan BG, Stein AP, Salgia R, Rolff J, Kimple RJ, Wheeler DL. Brand TM, et al. Among authors: salgia r. Sci Signal. 2021 Nov 9;14(708):eabn0168. doi: 10.1126/scisignal.abn0168. Epub 2021 Nov 9. Sci Signal. 2021. PMID: 34752142 Free PMC article. No abstract available.

2

Diagnosis and management of hereditary hemochromatosis.

Salgia RJ, Brown K. Salgia RJ, et al. Clin Liver Dis. 2015 Feb;19(1):187-98. doi: 10.1016/j.cld.2014.09.011. Epub 2014 Oct 23. Clin Liver Dis. 2015. PMID: 25454304 Review.

3

Crizotinib in ROS1-rearranged non-small-cell lung cancer.

Shaw AT, Ou SH, Bang YJ, Camidge DR, Solomon BJ, Salgia R, Riely GJ, Varella-Garcia M, Shapiro GI, Costa DB, Doebele RC, Le LP, Zheng Z, Tan W, Stephenson P, Shreeve SM, Tye LM, Christensen JG, Wilner KD, Clark JW, Iafrate AJ. Shaw AT, et al. Among authors: salgia r. N Engl J Med. 2014 Nov 20;371(21):1963-71. doi: 10.1056/NEJMoa1406766. Epub 2014 Sep 27. N Engl J Med. 2014. PMID: 25264305 Free PMC article. Clinical Trial.

4

Liver transplantation for hepatocellular carcinoma: Management after the transplant.

Verna EC, Patel YA, Aggarwal A, Desai AP, Frenette C, Pillai AA, Salgia R, Seetharam A, Sharma P, Sherman C, Tsoulfas G, Yao FY. Verna EC, et al. Among authors: salgia r. Am J Transplant. 2020 Feb;20(2):333-347. doi: 10.1111/ajt.15697. Epub 2019 Dec 9. Am J Transplant. 2020. PMID: 31710773 Free article. Review.

5

RNA-based therapies: A cog in the wheel of lung cancer defense.

Khan P, Siddiqui JA, Lakshmanan I, Ganti AK, Salgia R, Jain M, Batra SK, Nasser MW. Khan P, et al. Among authors: salgia r. Mol Cancer. 2021 Mar 19;20(1):54. doi: 10.1186/s12943-021-01338-2. Mol Cancer. 2021. PMID: 33740988 Free PMC article. Review.

6

Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.

Gong J, Chehrazi-Raffle A, Reddi S, Salgia R. Gong J, et al. Among authors: salgia r. J Immunother Cancer. 2018 Jan 23;6(1):8. doi: 10.1186/s40425-018-0316-z. J Immunother Cancer. 2018. PMID: 29357948 Free PMC article. Review.

7

Response.

Roosan MR, Mambetsariev I, Salgia R. Roosan MR, et al. Among authors: salgia r. Chest. 2021 Oct;160(4):e375-e376. doi: 10.1016/j.chest.2021.06.040. Chest. 2021. PMID: 34625192 No abstract available.

8

Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.

Shinde A, Li R, Kim J, Salgia R, Hurria A, Amini A. Shinde A, et al. Among authors: salgia r. Semin Oncol. 2018 Aug;45(4):210-219. doi: 10.1053/j.seminoncol.2018.06.002. Epub 2018 Jul 1. Semin Oncol. 2018. PMID: 30286944 Review.

9

Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy.

Aredo JV, Mambetsariev I, Hellyer JA, Amini A, Neal JW, Padda SK, McCoach CE, Riess JW, Cabebe EC, Naidoo J, Abuali T, Salgia R, Loo BW Jr, Diehn M, Han SS, Wakelee HA. Aredo JV, et al. Among authors: salgia r. J Thorac Oncol. 2021 Jun;16(6):1030-1041. doi: 10.1016/j.jtho.2021.01.1628. Epub 2021 Feb 12. J Thorac Oncol. 2021. PMID: 33588109

10

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC).

Salgia R, Pharaon R, Mambetsariev I, Nam A, Sattler M. Salgia R, et al. Cell Rep Med. 2021 Jan 19;2(1):100186. doi: 10.1016/j.xcrm.2020.100186. eCollection 2021 Jan 19. Cell Rep Med. 2021. PMID: 33521700 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results